Article
Biotechnology & Applied Microbiology
Suphalak Khamruang Marshall, Yada Panrak, Naritsara Makchuchit, Passara Jaroenpakdee, Boonyisa Saelim, Maneerat Taweesap, Verachai Pachana
Summary: This study developed a radiolabeled anti-EpCAM targeted biomimetic coated nanocarrier (EINP) for breast cancer treatment. The EINP showed high cytotoxic efficacy against breast cancer cells and had a favorable safety profile.
BIOENGINEERING-BASEL
(2022)
Review
Biochemistry & Molecular Biology
Mingming Song, Chang Liu, Siyu Chen, Wenxiang Zhang
Summary: Nanotechnologies show promise as an effective oncology treatment strategy by delivering drugs to targeted tissues with low toxicity, improving the clinical efficacy of cancer therapy. The application of nanoparticles in melanoma treatment has a broad potential, including chemotherapy, immunotherapy, mRNA vaccines, and photothermal therapy.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Materials Science, Multidisciplinary
Akhand Pratap Singh, Om Prakash, Sunil Kumar, Aparna Shukla, Pralay Maiti
Summary: The study demonstrates the suitability of poly(lactic acid-co-glycolic acid) (PLGA) as a sustained drug delivery vehicle for melanoma treatment. PLGA nanoparticles (NPs) and PLGA film encapsulated with paclitaxel (PTX) show greater efficacy in inhibiting melanoma cell proliferation and reducing tumor volume, compared to pure drug and control group. The sustained drug delivery systems also result in minimal damage to vital organs and fewer side effects.
MATERIALS TODAY COMMUNICATIONS
(2022)
Review
Nanoscience & Nanotechnology
So-Jung Kim, Nidhi Puranik, Dhananjay Yadav, Peter C. W. Lee, Jun -O Jin
Summary: Despite ongoing developments in various treatments, lung cancer continues to have high mortality rates, with many cases showing reduced survival rates due to treatment resistance. Cancer nanotechnology, specifically the use of lipid-based nanocarriers, has shown promise in enhancing drug delivery, overcoming absorption barriers, and targeting specific areas for lung cancer treatment and vaccine development.
INTERNATIONAL JOURNAL OF NANOMEDICINE
(2023)
Article
Biotechnology & Applied Microbiology
S. P. Surya Teja, N. Damodharan, T. Tamilanban, Vetriselvan Subramaniyan, V. Chitra, Suresh V. Chinni, Ling Shing Wong, Neeraj Kumar Fuloria, Mahendran Sekar, Shivkanya Fuloria, Gobinath Ramachawolran, Siddharthan Selvaraj
Summary: The aim of this study was to investigate the influence of excipients on retaining the particle size of methotrexate (MTX) loaded chitosan nanocarriers (CsNP) during lyophilization. The use of mannitol as a lyoprotectant resulted in restricted nanocarrier size and successful tumor targeting. This study demonstrates the potential of chitosan nanocarriers for targeted tumor drug delivery and cancer treatment.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
(2023)
Article
Pharmacology & Pharmacy
Mingming Song, Wentao Xia, Zixuan Tao, Bin Zhu, Wenxiang Zhang, Chang Liu, Siyu Chen
Summary: The study successfully developed a nanoparticle system based on biomaterials for co-delivery of MET and DOX into melanoma tumors, resulting in the inhibition of melanoma progression.
Review
Pharmacology & Pharmacy
Samruddhi Kulkarni, Bala Prabhakar, Pravin Shende
Summary: Aquasomes are a promising nanocarrier with multiple potential applications in the treatment of diseases such as hemophilia A, cancer, and hepatitis. They can enter target cells by modifying surface chemistry and provide prolonged drug release. With a larger surface area, volume, and mass ratio, aquasomes allow drugs to penetrate cells and exhibit a prolonged drug release profile.
CURRENT PHARMACEUTICAL DESIGN
(2022)
Review
Chemistry, Multidisciplinary
Rajeev Taliyan, Violina Kakoty, K. C. Sarathlal, Sanskruti Santosh Kharavtekar, Chandrashekar R. Karennanavar, Yogendra Kumar Choudhary, Gautam Singhvi, Yassine Riadi, Sunil Kumar Dubey, Prashant Kesharwani
Summary: Dementia is a progressive memory-related neurodegenerative disease observed in the geriatric population. The current therapeutics for Alzheimer's disease primarily target symptomatic management and face challenges in crossing the blood-brain barrier and blood-cerebrospinal fluid barrier. Nanocarriers show promise in facilitating targeted drug delivery for the management of Alzheimer's disease.
JOURNAL OF CONTROLLED RELEASE
(2022)
Review
Pharmacology & Pharmacy
Prashant Kesharwani, Rahul Chadar, Afsana Sheikh, Waleed Y. Rizg, Awaji Y. Safhi
Summary: Cluster of differentiation 44 (CD44) is a cell surface glycoprotein overexpressed in various solid tumors. It plays a significant role in cell proliferation, cell-to-cell interaction, cellular migration, inflammation, and immune responses. Nanocarriers have been developed to target the CD44 receptor and improve the efficacy of chemotherapy. Hyaluronic acid (HA) also plays a crucial role in cancer therapy and interacts with CD44, providing a potential approach for targeted therapy.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Chemistry, Multidisciplinary
Hengde Li, Shuai Zha, Haolan Li, Haito Liu, Ka-Leung Wong, Angelo H. All
Summary: Dendrimers are polymers with well-defined 3D branched structures that are widely used in neurotheranostics and biomedical applications, particularly as nanocarrier vectors. They can improve the accuracy of diagnostic imaging processes by loading imaging agents. Combining pharmaceutical agents and anticancer drugs with dendrimers enhances their solubility and efficiency, and modifying ligands on dendrimers' surface can construct effective targeted delivery systems.
Article
Pharmacology & Pharmacy
Meryem Kaplan, Kivilcim Ozturk, Suleyman Can Ozturk, Ece Tavukcuoglu, Gunes Esendagli, Sema Calis
Summary: The physicochemical properties of nanocarriers directly influence their biological behavior, and understanding their effect is crucial for the design of drug delivery systems. In this study, spherical, rod and elliptical disk-shaped PLGA nanoparticles were examined for their behavior. It was found that shape can affect the release of encapsulated substances, but not the safety of the nanoparticles within the studied concentration range.
Article
Chemistry, Multidisciplinary
Moritz Radbruch, Hannah Pischon, Fang Du, Rainer Haag, Fabian Schumacher, Burkhard Kleuser, Lars Mundhenk, Achim D. Gruber
Summary: The polymeric core-multishell nanocarrier (CMS) shows promise as a carrier for topical delivery of tacrolimus (TAC). However, in vivo, it does not increase TAC penetration into the skin compared to ointment. Nevertheless, the therapeutic efficacy of TAC delivered by CMS is equivalent to standard TAC ointment.
JOURNAL OF CONTROLLED RELEASE
(2022)
Article
Materials Science, Biomaterials
Zixuan Wang, Xuelin Zhang, Mingshan Han, Xinhao Jiao, Jialin Zhou, Xinyao Wang, Rongxin Su, Yuefei Wang, Wei Qi
Summary: An ultra pH-responsive peptide nanocarrier that can efficiently and precisely target cancer cells to release gene drugs was reported. It has high transfection efficiency, lysosomal escape ability, targeting capability, and cytotoxicity, which makes it highly promising for application in immunotherapy and gene therapy of tumors.
JOURNAL OF MATERIALS CHEMISTRY B
(2023)
Article
Nanoscience & Nanotechnology
Haoyuan Yin, Hongdan Lu, Yaokun Xiong, Lu Ye, Chuanhui Teng, Xiang Cao, Shengnan Li, Shanbo Sun, Wentao Liu, Wei Lv, Hongliang Xin
Summary: The smart nanocarrier mP-NPs-DNase/PTX can degrade NETs structure by releasing DNase I at tumor tissue, mediate tumor cell uptake through exposed cell penetrating peptide, and exert cytotoxic effect by releasing PTX. It shows potential as a NET-regulated nanocarrier for inhibiting malignant tumor growth and metastasis.
ACS APPLIED MATERIALS & INTERFACES
(2021)
Article
Engineering, Biomedical
Sung Eun Lee, Chan Mi Lee, Ji Eun Won, Gun-Young Jang, Ju Hyeong Lee, Sang Hyeon Park, Tae Heung Kang, Hee Dong Han, Yeong-Min Park
Summary: This study demonstrates a selective nanocarrier system that enhances cytotoxic T cell immunity against tumor-specific antigens, increases survival rates of immune-activating cells, and reduces tumor mass by decreasing immune-suppressive cells and anti-inflammatory cytokines. Combining the nanocarrier system with other ICIs further amplifies the anticancer immunity of interferon gamma+ (IFN-gamma) CD8+ T cells.